Dyspnea and related symptoms suggesting pulmonary embolism should also raise suspicion for possible chronic thromboembolic pulmonary hypertension. In this video, a multidisciplinary panel walks through considerations in differentiating the conditions and finding the best treatment strategy.
A recent study compared levels of HDL-C in CTEPH patients with those found in PAH patients and controls and assessed the association between HDL-C and markers of disease severity and survival.
Up to 40 percent of patients with chronic thromboembolic pulmonary hypertension aren’t eligible for surgery. For them, balloon pulmonary angioplasty is emerging as a highly promising new therapy.
The good news about chronic thromboembolic pulmonary hypertension (CTEPH)? Surgery is curative in over 90 percent of cases. The bad news? Physicians need to get a lot better at spotting it.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
While the incidence of CTEPH is low, diagnosis is important by a specialized multidisciplinary program that can provide a surgical cure.
Pulmonary thromboendarterectomy provides significantly prolonged life expectancy for heart-lung transplant patient at Cleveland Clinic.